Method of treating polycystic kidney diseases with ceramide derivatives

Details for Australian Patent Application No. 2008307516 (hide)

Owner GENZYME CORPORATION

Inventors Yew, Nelson S.; Leonard, John P.; Natoli, Thomas A.; Cheng, Seng H.; Ibraghinov-Beskrovnaya, Oxana

Agent A J Park

Pub. Number AU-B-2008307516

PCT Pub. Number WO2009/045503

Priority 60/997,803 05.10.07 US

Filing date 3 October 2008

Wipo publication date 9 April 2009

Acceptance publication date 17 November 2011

International Classifications

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 13/02 (2006.01) Drugs for disorders of the urinary system

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/045503 Priority application(s): WO2009/045503

17 November 2011 Application Accepted

  Published as AU-B-2008307516

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008307519-Skeletal muscle augmentation utilizing muscle-derived progenitor compositions, and treatments thereof

2008307510-Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides